(IN BRIEF) Novo Nordisk’s SOUL trial has shown that oral semaglutide reduces the risk of major adverse cardiovascular events (MACE)…
(IN BRIEF) Sanofi and CD&R have entered exclusive negotiations for CD&R to acquire a 50% controlling stake in Opella, Sanofi’s…
(IN BRIEF) Novo Nordisk’s Alhemo® (concizumab) has been recommended for approval by the European Medicines Agency's (EMA) Committee for Medicinal…
(IN BRIEF) Sanofi and Orano Med have partnered to accelerate the development of next-generation radioligand therapies (RLTs) for rare cancers.…
M7 Intelli IT AFib X7 Smart AFib M6 Comfort AFib HET NIEUWE INTELLISENSE AFIB-ALGORITME ONTDEKT MOGELIJKE ATRIUMFIBRILLATIE BIJ ELKE CONTROLE…
M7 Intelli IT AFib X7 Smart AFib M6 Comfort AFib LE NOUVEL ALGORITHME INTELLISENSE AFIB DÉTECTE UNE ÉVENTUELLE FIBRILLATION AURICULAIRE…
M7 Intelli IT AFib X7 Smart AFib M6 Comfort AFib IL NUOVO ALGORITMO INTELLISENSE AFIB RILEVA UNA POSSIBILE FIBRILLAZIONE ATRIALE…
M7 Intelli IT AFib X7 Smart AFib M6 Comfort AFib EL NUEVO ALGORITMO AFIB INTELLISENSE DETECTA UNA POSIBLE FIBRILACIÓN AURICULAR…
(IN BRIEF) AstraZeneca presented significant advancements in the prevention of infectious diseases at IDWeek 2024, showcasing its dedication to addressing…
(IN BRIEF) Boehringer Ingelheim and the WHO Foundation have partnered to promote equitable healthcare access and suicide prevention, with a…